Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.19
-0.23 (-1.60%)
At close: Aug 15, 2025, 10:20 AM
-1.60% (1D)
| Bid | 14.17 |
| Market Cap | 576.33M |
| Revenue (ttm) | 232.84M |
| Net Income (ttm) | 18.77M |
| EPS (ttm) | 0.32 |
| PE Ratio (ttm) | 44.34 |
| Forward PE | -3.24 |
| Analyst | Hold |
| Ask | 14.19 |
| Volume | 72,626 |
| Avg. Volume (20D) | 530,517 |
| Open | 14.42 |
| Previous Close | 14.42 |
| Day's Range | 14.13 - 14.48 |
| 52-Week Range | 9.12 - 72.37 |
| Beta | 1.33 |
About KROS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KROS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KROS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Keros Therapeutics has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
Keros Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-7.29%
Keros Therapeutics shares are trading lower follow...
Unlock content with
Pro Subscription
4 months ago
+18.49%
Keros Therapeutics shares are trading higher. The company announced that its board has initiated a formal review process to evaluate strategic alternatives to maximize shareholder value.
2 months ago · https://thefly.com
BofA says Keros cost reduction 'disappoints,' still sees reasons to like story04 Jun